LEAF-4L6715

N/A

Report date: 2024/11/26 14:38:34
NME

Base Information

Drug NameLEAF-4L6715
Drug Alias NameLEAF-4L6715
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, AdultSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesLeaf4life Llc
China Registration ClassN/A

Develop Information

Active CompaniesInstitut De Cancerologie Strasbourg EuropeLeaf4life Llc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, AdultSepsis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A